Quantcast

Latest Vancomycin Stories

2014-09-08 16:25:18

Phase I/II study also demonstrated SER-109 restoration of a diverse, healthy microbiome CAMBRIDGE, Mass., Sept. 8, 2014 /PRNewswire/ -- Seres Health, a clinical-stage therapeutics company developing novel treatments for diseases related to the human microbiome, today announced final data for its single-arm, open-label clinical trial of SER-109, its first-in-field, oral microbiome therapeutic. SER-109, a mixture of bacterial spores, is designed for the treatment of recurrent...

2014-09-08 08:30:48

Data demonstrate potent, broad spectrum activity against gram-positive and gram-negative bacteria, including resistant organisms that cause skin infections NEW YORK, Sept. 8, 2014 /PRNewswire/ -- Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX), a late stage pharmaceutical company focused on the development and commercialization of Locilex® (pexiganan cream 0.8%), and research collaborators, today announced updated data from a microbiology study of Locilex® were presented at the 54th...

antibiotics
2014-08-19 04:00:12

Heather Amos, University of British Columbia New University of British Columbia research found that receiving antibiotic treatments early in life can increase susceptibility to specific diseases later on. Most bacteria living in the gut play a positive role in promoting a healthy immune system, but antibiotic treatments often do not discriminate between good and bad bacteria. The study published August 18 in Journal of Allergy and Clinical Immunology helps scientists understand how...

2014-08-01 16:24:06

BAUDETTE, Minn., Aug. 1, 2014 /PRNewswire/ -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) today announced that it has acquired the US rights for Vancocin® 125 mg and 250 mg capsules from Shire plc, a global biopharmaceutical company. In addition, ANI acquired from Shire approved ANDAs for the currently non-marketed products vancomycin hydrochloride injectable 500 mg, 1 gm and 10 gm ($45 million in 2013 market value, per IMS Health) and vancomycin hydrochloride oral solution 250 mg...

2014-07-07 12:28:56

To Effectively Compete with Current Anti-MRSA Therapies, Emerging Agents Will Need to be Amenable to Outpatient Use, According to Findings from Decision Resources Group BURLINGTON, Mass., July 7, 2014 /PRNewswire/ -- Decision Resources Group finds that, although vancomycin continues to be the standard-of-care for infections caused by methicillin-resistant Staphylococcus aureus (MRSA), there is growing concern among infectious disease (ID) specialists over rising vancomycin minimum inhibitory...

2014-06-19 04:21:30

LAUSANNE, Switzerland, June 19, 2014 /PRNewswire/ -- Debiopharm Group(TM)(Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs as well as companion diagnostics, today announced the launch of a Phase 1 dose-escalation study of Debio 1450 (previously known as AFN-1720), a highly potent anti-infective agent that is selectively active against a large number of Staphylococcus species, including all known...

2014-05-28 12:23:42

As the dangers of the antibiotic-resistant bacteria known as MRSA, in addition to others, become more prevalent due to the overzealous use of antibiotics on livestock farms, Clearstream says that antimicrobial technologies and advanced long-term application protocols are part of the solution in containing the spread of viral and bacterial contaminants and protecting the public's health. HARRISBURG, N.C., May 28, 2014 /PRNewswire-iReach/ -- Studies have shown that farmworkers, as well as those...

2014-04-30 08:32:05

FIRST® - Vancomycin compounding kits make pharmacy compounding easier WOBURN, Mass., April 30, 2014 /PRNewswire/ -- CutisPharma, Inc. announced the introduction of FIRST(® )- Vancomycin oral solution compounding kits. With FIRST(®) - Vancomycin, the oral solution is compounded within a minute by adding the pre-measured white grape flavored solution to the pre-weighed vancomycin hydrochloride powder bottle and shaking it. The pleasant white grape flavor helps mask the typical...

2014-04-25 09:18:08

Mass. General study identifies more acceptable way to administer treatment for dangerous recurrent infection A pilot study by Massachusetts General Hospital (MGH) investigators may lead to greater availability and acceptability of an unusual treatment for a serious medical problem – use of fecal material from healthy donors to treat recurrent diarrhea caused by the Clostridium difficile (C. difficile) bacteria. In their paper being published online in the journal Clinical Infectious...

2014-03-10 08:31:26

But 19 in 20 patients with a history of penicillin "allergy" are not penicillin allergic ROUND ROCK, Texas, March 10, 2014 /PRNewswire/ -- A new study in the Journal of Allergy and Clinical Immunology, funded by ALK, finds that a penicillin "allergy" label adversely affects the quantity and quality of health care in hospitalized patients. The penicillin allergy label is the most common drug "allergy" listed in medical records during hospital admissions. Analyzing Kaiser Foundation...


Latest Vancomycin Reference Libraries

0_4d46cc72a490344d44ba78359f528175
2011-04-26 21:07:20

Enterococcus is a Gram-positive, commensal bacterium inhabiting the gastrointestinal tracts of humans and other mammals. It is a main constituent of some probiotic food supplements. E. faecalis can cause life-threatening infections in humans, especially in the nosocomial environment, where the naturally high levels of antibiotic resistance found in E. faecalis contribute to its pathogenicity. It is frequently found in root canal-treated teeth in prevalence values ranging from 30% to 90% of...

0_71ad70ea6f0948a7e84406e760c7f5a4
2011-04-15 14:36:05

Enterococcus faecalis "“ formerly classified as part of the Group D Streptococcus system "“ is a Gram-positive, commensal bacterium inhabiting the gastrointestinal tracts of humans and other mammals. It is one of the main constituents of some probiotic food supplements. E. faecalis can cause life-threatening infections in humans. It is frequently found in root canal-treated teeth in prevalence values ranging from 30% to 90% of the cases. It is a non-motile, facultatively anaerobic...

More Articles (2 articles) »
Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related